From: Lower circulating endocannabinoid levels in children with autism spectrum disorder
AEA | OEA | PEA | |
---|---|---|---|
ADOS comparison score [R (P)]# | 0.01 (0.9) | 0.06 (0.5) | 0.07 (0.4) |
VABS standard score [R (P)]# | − 0.02 (0.8) | − 0.05 (0.6) | 0.09 (0.4) |
CARS summary score [R (P)]# | − 0.15 (0.15) | − 0.08 (0.3) | − 0.03 (0.7) |
DSM-5: level of support required in social communication [R (P)]# | − 0.11 (0.29) | 0.01 (0.89) | 0.03 (0.9) |
DSM-5: level of support required in repetitive restricted behavior [R (P)]# | − 0.01 (0.9) | 0.01 (0.89) | − 0.01 (0.7) |
CGI-S, behavior [R (P)]# | − 0.09 (0.3) | 0.05 (0.2) | 0.13 (0.2) |
CGI-S, anxiety [R (P)]# | 0.08 (0.8) | 0.11 (0.6) | 0.07 (0.4) |
Family history of ASD [yes/no; χ2 (P)]# | 1.13 (0.6) | 0.11 (0.73) | 1.05 (0.58) |
Perinatal complications [yes/no; χ2 (P)]# | 0.02 (0.8) | 0.53 (0.4) | 0.44 (0.8) |
Epilepsy comorbidity [yes/no; χ2 (P)]# | 0.26 (0.6) | 0.64 (0.42) | 2.18 (0.3) |
ADHD [yes/no; χ2 (P)]# | 1.84 (0.07) | 1.12 (0.26) | 1.5 (0.13) |
Medications | |||
Any [yes/no; χ2 (P)]# | 1.71 (0.19) | 1.45 (0.2) | 3.51 (0.17) |
Antipsychotic [number; R (P)]# | 0.18 (0.07) | 0.14 (0.17) | 0.02 (0.8) |
SSRIs [yes/no; χ2 (P)]# | 0.13 (0.7) | 0.68 (0.7) | 0.48 (0.7) |
Stimulants [yes/no; χ2 (P)]# | 0.93 (0.6) | 0.94 (0.3) | 2.10 (0.3) |
Antiepileptic [yes/no; χ2 (P)]# | 0.45 (0.5) | 0.58 (0.45) | 0.81 (0.37) |
HSQ total score [R (P)]# | 0.07 (0.5) | − 0.04 (0.7) | 0.03 (0.8) |
APSI—total score [R (P)]# | − 0.19 (0.06) | − 0.03 (0.7) | 0.08 (0.4) |
Parents SRS—t score [R (P)]# | − 0.48 (0.6) | 0.06 (0.3) | − 0.08 (0.4) |
CBCL—externalizing score [R (P)]# | 0.04 (0.6) | 0.12 (0.2) | 0.08 (0.4) |
SCQ—summary score [R (P)]# | − 0.02 (0.8) | 0.05 (0.6) | 0.01 (0.8) |